| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.26 | 6e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.28 | 7e-07 |